BML (4694) Q1 2027 earnings summary

Executive summary

• Net sales for the first three months rose 2.7% year-over-year to ¥39,036 million, driven by new customer acquisition and price optimization.

• Operating profit increased 7.0% year-over-year to ¥3,000 million, and profit attributable to owners of parent grew 6.3% to ¥1,980 million.

• The business environment remains challenging due to rising costs and labor shortages, despite no reduction in medical service fees.

Financial highlights

• Gross profit for the quarter was ¥13,089 million, up from ¥12,516 million year-over-year.

• Basic earnings per share increased to ¥52.85 from ¥47.75 year-over-year.

• Total assets at quarter-end were ¥179,931 million, down ¥3,316 million from the previous fiscal year-end.

• Equity ratio improved to 70.6% from 69.7% at the previous fiscal year-end.

Outlook and guidance

• Full-year net sales forecast is ¥155,000 million, up 3.2% year-over-year.

• Operating profit for the full year is projected at ¥10,500 million, a 0.8% increase year-over-year.

• Profit attributable to owners of parent is forecast to decline 9.7% year-over-year to ¥7,000 million.

• No changes have been made to previously announced forecasts.